stars 1 stars 2 stars 3

Peloton Therapeutics, Inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton Therapeutics’ lead programs are small molecule inhibitors targeting hypoxia inducible factor-2α (HIF-2α), a transcription factor implicated in the development and progression of kidney and other cancers.

View Top Employees from Peloton Therapeutics
Revenue $8.8 million
Funding $104.3 million
Employees 27 (11 on RocketReach)
Founded 2011
Phone (972) 629-4100
JavaScript, HTML, Twitter +10 more (view full list)
Category Pharmaceuticals, Biotechnology, Oncology, Healthcare, Science and Engineering, Small molecule, Drug Manufacturing & Research, Medical Device, Drug discovery, Health Care, Drug development, Pharmaceutical, Immuno-oncology, Therapeutics
Web Rank 1 Million
Keywords peloton therapeutics, peloton therapeutics, inc., hif-2α inhibitor, bicycle therapeutics plc, peloton therapeutics,
Competitors Hansa Medical AB, Lengo Therapeutics, Selecta Biosciences, Tarveda Therapeutics
SIC 283, 2834, 28
NAICS 325, 32, 32541, 3254

Peloton Therapeutics Questions

The Peloton Therapeutics annual revenue was $8.8 million in 2023.

11 people are employed at Peloton Therapeutics.

Peloton Therapeutics is based in Dallas, Texas.

The NAICS codes for Peloton Therapeutics are [325, 32, 32541, 3254].

The SIC codes for Peloton Therapeutics are [283, 2834, 28].

Top Peloton Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users